EUSEBI, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 3.569
EU - Europa 3.083
AS - Asia 2.355
SA - Sud America 381
AF - Africa 37
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 9.431
Nazione #
US - Stati Uniti d'America 3.492
IT - Italia 1.116
SG - Singapore 1.104
IE - Irlanda 551
CN - Cina 397
HK - Hong Kong 354
BR - Brasile 336
RU - Federazione Russa 258
VN - Vietnam 256
DE - Germania 224
UA - Ucraina 190
FR - Francia 139
FI - Finlandia 134
SE - Svezia 98
GB - Regno Unito 95
NL - Olanda 69
KR - Corea 55
IN - India 51
RO - Romania 40
CA - Canada 37
TR - Turchia 34
PL - Polonia 32
MX - Messico 26
AT - Austria 25
CH - Svizzera 23
CZ - Repubblica Ceca 23
JP - Giappone 21
ES - Italia 20
AR - Argentina 18
IQ - Iraq 17
ZA - Sudafrica 17
BD - Bangladesh 16
BE - Belgio 15
LT - Lituania 11
UZ - Uzbekistan 11
ID - Indonesia 10
GR - Grecia 8
CO - Colombia 6
VE - Venezuela 6
CL - Cile 5
JM - Giamaica 5
JO - Giordania 5
MA - Marocco 5
BG - Bulgaria 3
CI - Costa d'Avorio 3
EC - Ecuador 3
KE - Kenya 3
PY - Paraguay 3
SA - Arabia Saudita 3
AU - Australia 2
AZ - Azerbaigian 2
CR - Costa Rica 2
DK - Danimarca 2
DZ - Algeria 2
EG - Egitto 2
EU - Europa 2
HN - Honduras 2
HR - Croazia 2
KG - Kirghizistan 2
NP - Nepal 2
OM - Oman 2
PA - Panama 2
PK - Pakistan 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TJ - Tagikistan 2
TN - Tunisia 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
BS - Bahamas 1
CY - Cipro 1
DM - Dominica 1
GA - Gabon 1
GE - Georgia 1
GY - Guiana 1
IL - Israele 1
LB - Libano 1
LV - Lettonia 1
MO - Macao, regione amministrativa speciale della Cina 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PE - Perù 1
PT - Portogallo 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 9.431
Città #
Singapore 749
Chandler 650
Dublin 551
Hong Kong 348
Perugia 301
San Mateo 258
Ashburn 203
Boardman 181
Santa Clara 138
Altamura 135
Wilmington 129
Dong Ket 121
Beijing 115
Medford 113
Princeton 112
Munich 97
Lawrence 95
Jacksonville 91
Moscow 84
Des Moines 79
Andover 69
Los Angeles 64
Milan 62
Seoul 55
Ho Chi Minh City 51
Rome 51
Ann Arbor 47
New York 43
Helsinki 40
Turku 35
The Dalles 33
Hanoi 31
Bucharest 30
São Paulo 30
Houston 25
Frankfurt am Main 23
Norwalk 23
Saint Petersburg 23
Chennai 22
Nuremberg 22
Salerno 21
Denver 20
Izmir 20
Atlanta 19
Brooklyn 19
Dallas 19
Falls Church 19
Bologna 18
Chicago 18
Poplar 18
Tokyo 16
Warsaw 16
Brussels 15
Mexico City 15
Phoenix 15
Piscataway 15
Seattle 15
Brno 14
Falkenstein 14
Redwood City 14
Amsterdam 13
Johannesburg 13
Montreal 13
San Paolo di Civitate 13
Dearborn 12
Genoa 12
Modena 12
Boston 11
Haiphong 11
London 11
Manchester 11
Stockholm 11
Hefei 10
Orem 10
Saint Louis 10
San Francisco 10
Turin 10
Verona 10
Vienna 10
Ankara 9
Columbus 9
Lausanne 9
Padova 9
Shanghai 9
Catania 8
Mumbai 8
Parma 8
Rio de Janeiro 8
Trento 8
Woodbridge 8
Fairfield 7
Laion 7
Lucca 7
Oklahoma City 7
Porto Alegre 7
Toronto 7
Baghdad 6
Belo Horizonte 6
Brasília 6
Florence 6
Totale 6.041
Nome #
The validation of an Italian version of the Freezing of Gait Questionnaire 647
CSF and blood biomarkers for Parkinson's disease 169
Deviation from intention to treat analysis in randomised trials and treatment effect estimates: meta-epidemiological study 138
A diagnostic accuracy study validating cardiovascular ICD-9-CM codes in healthcare administrative databases. The Umbria data-value project 130
Interatrial Shunting Through an Asymptomatic Patent Foramen Ovale in Thoracic Surgery 122
Accuracy of ICD-9 codes in identifying patients with peptic ulcer and gastrointestinal hemorrhage in the regional healthcare administrative database of Umbria 121
Disturbi del comportamento alimentare nei maschi: l'importanza della distorsione dell'immagine corporea. 118
Cerebrospinal fluid free light chains compared to oligoclonal bands as biomarkers in multiple sclerosis 118
Cerebrospinal fluid β-glucocerebrosidase activity is reduced in parkinson's disease patients 117
Time trends, frequency, characteristics and prognosis of short-duration transient global amnesia 117
Validating malignant melanoma ICD-9-CM codes in Umbria, ASL Napoli 3 Sud and Friuli Venezia Giulia administrative healthcare databases: a diagnostic accuracy study 116
Diagnostic performance of a fully automated chemiluminescent enzyme immunoassay for Alzheimer's disease diagnosis 107
Characterization of Brain Lysosomal Activities in GBA-Related and Sporadic Parkinson’s Disease and Dementia with Lewy Bodies 105
The added value of Aβ42/Aβ40 in the CSF signature for routine diagnostics of Alzheimer's disease 104
Performance of Aβ1-40, Aβ1-42, Total Tau, and Phosphorylated Tau as Predictors of Dementia in a Cohort of Patients with Mild Cognitive Impairment. 103
Selective loss of glucocerebrosidase activity in sporadic Parkinson's disease and dementia with Lewy bodies 103
Dural arteriovenous fistulas and headache features: an observational study 103
Brain arteriovenous malformations and seizures: an Italian study. 102
Multilevel Latent Class Models for evaluation of long term care facilities 101
A magnetization transfer study of mild and advanced Parkinson's disease. 101
A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation 100
Diagnostic utility of cerebrospinal fluid α-synuclein in Parkinson's disease: A systematic review and meta-analysis 100
Cerebrospinal fluid neurofilament light chain tracks cognitive impairment in multiple sclerosis 98
Stima della non autosufficienza negli anziani in Umbria 97
Cerebrospinal fluid lysosomal enzymes and α-synuclein in Parkinson's disease. 96
Alzheimer's disease and late-onset epilepsy of unknown origin: two faces of beta amyloid pathology 96
Substantia nigra hyperechogenicity in essential tremor and Parkinson's disease: a longitudinal study 96
Validity of cerebrovascular ICD-9-CM codes in healthcare administrative databases. The Umbria Data-Value Project 95
Applicazione della Scala Sulla Qualita della vita nelle residenze protette dell'Umbria 94
2017 revisions of McDonald criteria shorten the time to diagnosis of multiple sclerosis in clinically isolated syndromes 94
Occipital arteriovenous malformations andmigraine. 93
Predictive value of admission blood glucose level on short-term mortality in acute cerebral ischemia. 92
Changes in endolysosomal enzyme activities in cerebrospinal fluid of patients with Parkinson's disease. 92
Lysosomal enzyme activities in human brain 92
Health technology disinvestment worldwide: Overview of programs and possible determinants 91
Association between migraine and headache attributed to stroke: a case-control study. 89
Extracranial Venous Drainage Pattern in Multiple Sclerosis and Healthy Controls: Application of the 2011 Diagnostic Criteria for Chronic Cerebrospinal Venous Insufficiency 89
A 1H magnetic resonance spectroscopy study in patients with obstructive sleep apnea. 88
Cerebrospinal fluid biomarkers for the diagnosis and prognosis of Parkinson's disease: protocol for a systematic review and individual participant data meta-analysis 88
Impulse Control Disorders and Levodopa-Induced Dyskinesias in Parkinson's Disease: Pulsatile versus Continuous Dopaminergic Stimulation 88
Lower urinary tract symptoms and urodynamic dysfunction in clinically isolated syndromes suggestive of multiple sclerosis 88
Reliability and validity of the Italian versions of the Children's Fear Survey Schedule Dental Subscale and the Modified Child Dental Anxiety Scale 88
Cerebrospinal fluid biomarkers in Alzheimer's and Parkinson's diseases-From pathophysiology to clinical practice 88
Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias. 87
Prevalence and risk of progression of preclinical Alzheimer's disease stages: A systematic review and meta-analysis 87
Distorsione dell'immagine corporea nei DCA nei maschi 86
Epilepsy, amyloid-β, and D1 dopamine receptors: a possible pathogenetic link? 85
Changes of olfactory tract in Parkinson’s disease: a DTI tractography study 84
Cerebrospinal fluid hemoglobin levels as markers of blood contamination: relevance for α-synuclein measurement 84
Underrecognition and undertreatment of dementia in Italian nursing homes. 83
Synaptic vesicle protein 2A tumoral expression predicts levetiracetam adverse events 82
Oral health knowledge level of nursing staff working in semi-intensive heart failure units 82
T2*-weighted MRI values correlate with motor and cognitive dysfunction in Parkinson's disease 81
The Italian version of cognitive function instrument (CFI): reliability and validity in a cohort of healthy elderly 80
Novel noninvasive biomarkers of prodromal Alzheimer disease: The role of optical coherence tomography and optical coherence tomography–angiography 80
Fingerprinting Alzheimer's Disease by 1H Nuclear Magnetic Resonance Spectroscopy of Cerebrospinal Fluid 79
Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia 79
Treatment of multiple sclerosis relapses with high-dose methylprednisolone reduces the evolution of contrast-enhancing lesions into persistent black holes 78
The Italian version of Cognitive Function Instrument (CFI) for tracking changes in healthy elderly: results at 1-year follow-up 78
White Matter Hyperintensities Are No Major Confounder for Alzheimer's Disease Cerebrospinal Fluid Biomarkers 77
A systematic review found that deviations from intention-to-treat are common in randomized trials and systematic reviews 76
Protocol for validating cardiovascular and cerebrovascular ICD-9-CM codes in healthcare administrative databases: The Umbria Data Value Project 76
Cerebrospinal Fluid Biomarkers in Alzheimer's Disease: An Invaluable Tool for Clinical Diagnosis and Trial Enrichment 76
Long-Term Risk of Stroke After Transient Global Amnesia in Two Prospective Cohorts 75
Liverpool Adverse Events Profile: Italian validation and predictive value for dropout from antiepileptic treatment in people with epilepsy 75
Diagnostic utility of CSF α-synuclein species in Parkinson's disease: Protocol for a systematic review and meta-analysis 74
Cerebrospinal Fluid Aβ42/40 Corresponds Better than Aβ42 to Amyloid PET in Alzheimer's Disease 74
Misure relative all'obiettivo di salute numero uno del PSR 2003-2005: aspettativa di vita con e senza disabilità nella popolazione umbra. Anni 1999-2000 e 2004-2005 73
Performance Evaluation of an Automated ELISA System for Alzheimer's Disease Detection in Clinical Routine 73
Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes 71
Obsessive-compulsive disorder and migraine with medication-overuse headache. 71
Le condizioni di salute della popolazione anziana 70
Drug-dependence behaviour and outcome of medication-overuse headache after treatment 70
Evidence of practice effect in CANTAB spatial working memory test in a cohort of patients with mild cognitive impairment 70
Reciprocal Incremental Value of 18F-FDG-PET and Cerebrospinal Fluid Biomarkers in Mild Cognitive Impairment Patients Suspected for Alzheimer's Disease and Inconclusive First Biomarker 69
New pathological findings in an international cohort of hereditary spastic paraplegia 4 patients. 68
Degradation of endocannabinoids in chronic migraine and medication overuse headache. 68
Stopping onabotulinum treatment after the first two cycles might not be justified: Results of a real-life monocentric prospective study in chronic migraine 68
Cerebrospinal fluid and serum D-serine concentrations are unaltered across the whole clinical spectrum of Alzheimer's disease 68
Neuropsychiatric adverse events of antiepileptic drugs in brain tumour-related epilepsy: an Italian multicentre prospective observational study 67
Parkinson's and Lewy body dementia CSF biomarkers 67
Early management of patients with medication-overuse headache: results from a multicentre clinical study 66
High risk of early conversion to multiple sclerosis in clinically isolated syndromes with dissemination in space at baseline 66
The possible role of Optical Coherence Tomography (OCT) and OCT‐Angiography (OCTA) as new non‐invasive biomarkers of prodromal Alzheimer’s disease 66
Fibroblast growth factor-2 levels are elevated in the cerebrospinal fluid of multiple sclerosis patients. 65
Stima della non autosufficienza negli anziani in Umbria 64
Le condizioni di salute della popolazione anziana in Umbria 64
Cerebrospinal fluid neurofilament light chain predicts disease activity after the first demyelinating event suggestive of multiple sclerosis 64
Incidence and Antiseizure Medications of Post-stroke Epilepsy in Umbria: A Population-Based Study Using Healthcare Administrative Databases 64
Condizioni di salute della popolazione anziana in Umbria negli anni 2004-2005 63
Factors influencing the measurement of lysosomal enzymes activity in human cerebrospinal fluid. 63
Risk factors of levodopa-induced dyskinesia in Parkinson's disease: results from the PPMI cohort 61
Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease. 60
No diurnal variation of classical and candidate biomarkers of Alzheimer's disease in CSF 60
Subclinical vestibular dysfunction in migraineurs without vertigo: A Clinical study 60
Latent variable modeling of disability in people aged 65 or more 60
Multilevel Latent Class Models for evaluation of long term care facilities 59
Cerebrospinal Fluid Biomarkers for Target Engagement and Efficacy in Clinical Trials for Alzheimer's and Parkinson's Diseases 59
Discovery, validation and optimization of cerebrospinal fluid biomarkers for use in Parkinson’s disease 57
Longitudinal changes in CSF alpha-synuclein species reflect Parkinson's disease progression 56
Totale 9.042
Categoria #
all - tutte 44.013
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.013


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021349 0 0 0 0 0 18 36 43 66 17 31 138
2021/20221.066 10 189 10 26 39 15 17 279 42 74 197 168
2022/20232.007 123 392 27 173 131 246 6 94 712 5 58 40
2023/2024884 40 82 39 28 18 21 197 38 42 42 150 187
2024/20252.038 48 142 82 132 211 151 111 179 369 124 318 171
2025/20262.116 274 279 245 544 654 120 0 0 0 0 0 0
Totale 9.770